Competitive intelligence analysis on Roche and DexCom: Comparative study of diabetes care market strategies and innovations.

This project provided insights to optimize market positioning in diabetes care, drive innovation in CGM technology, and support infrastructure expansion for global growth.

Outcome

  • Analysis of DexCom’s capacity expansion, automation initiatives, and global footprint, alongside Roche’s advancements in CGM technology and strategic shift toward diabetes management services.
  • Identification of unmet market needs, customer perceptions, and regulatory challenges, providing the client with targeted recommendations to strengthen competitive positioning and drive innovation.
  • A comparative review of Roche and DexCom’s strategies, market positioning, and infrastructure plans, highlighting opportunities and risks for the client and other market players.

KEY INTELLIGENCE OBJECTIVES

  • Evaluate the market positioning and strategies of Roche and DexCom in the diabetes care market, including plans for expanding global presence and infrastructure.
  • Analyze the capacity expansion potential of DexCom’s G4 production, including additional infrastructure, automation plans, and geographical distribution between facilities.
  • Assess DexCom’s strategic approach to sales and marketing infrastructure, comparing plans for direct operations versus distributor networks in key regions.
  • Examine Roche’s strategic evolution towards diabetes management services and the autonomy of its Diabetes Unit in driving innovation and business development over the next 3-5 years.
  • Investigate the development and technological focus behind Roche’s continuous glucose monitoring (CGM) sensor, including chemistry, wear period extensions, and competitive positioning.
  • Compare the product portfolios of Roche and DexCom, with a focus on innovations such as automation in manufacturing and advancements in CGM technology.
  • Identify the customer perception and brand loyalty of Roche and DexCom among healthcare professionals and patients, particularly in emerging markets.
  • Map the regulatory and reimbursement landscape impacting the adoption of Roche and DexCom’s diabetes care solutions globally.
  • Highlight unmet needs in the diabetes care market, assessing how Roche and DexCom address these gaps.

Geography

  • Western Europe
  • Central & Eastern Europe
  • Middle East
  • Africa
  • North America
  • South America
  • Other

    • Go back to our case studies

    Welcome to EMBS Group

    Please review the basic information regarding the processing of personal data. The Data Administrator is EMBS GROUP Sp. z o.o. Sp. k. You can contact us via email at gdpr@embs-group.com or our registered office (Poland, 30-224 Kraków, Aleja Sosnowa 2a).

    Please note that any personal data you provide may be used only for the specific purpose for which it was shared. Although providing your data is voluntary, not doing so may limit certain services or actions.

    For more detailed information on processing personal data, including exercising your rights, please refer to our Privacy Policy.

    Accept

    Get the report

    SUBSCRIBE TO MARKET MINDS

    Smart decisions start here.
    Unlock hard-to-get market intelligence to empower your next strategic move.

    Contact us

    Want to talk about your business challenge with us?
    Let us know, we’re always happy to talk.

    EMBS GROUP Sp. z o.o. Sp. k., as the Data Administrator, will process the personal data provided above to respond to the message sent via the form. You can contact us at gdpr@embs-group.com or our registered office (Poland, 30-224 Kraków, Aleja Sosnowa 2a). The full text of the information clause is available in the Privacy Policy.
    Privacy Overview

    EMBS Group, as the Data Administrator, uses cookies to enhance user experience and analyze website traffic. You can change your cookie settings at any time. For more information, please see our Privacy Policy.